An analysis of two large cohorts suggested increased pancreatic cancer risk was tied to: According to cross-sectional data, ...

Days after Meagan Brazil-Sheehan's 6-year-old son was diagnosed with leukemia, they were walking down the halls of UMass ...

Late last year, the FDA approved a subcutaneous formulation of the PD-1 inhibitor nivolumab plus hyaluronidase (Opdivo ...

TORONTO -- Linvoseltamab (Lynozyfic) appeared effective in patients with high-risk smoldering multiple myeloma (HR-SMM), according to preliminary phase II trial data.

I believe we are breaking some news here. My thanks to Polly Powledge for quickly analyzing the Wayback Machine archive to create the resource found at the bottom of this page. And, as always, my ...

LAGOS, Nigeria -- The World Health Organization (WHO) said Thursday that 31 of 38 confirmed Ebola cases have resulted in ...

TORONTO -- Achieving minimal residual disease (MRD) negativity was associated with favorable safety outcomes and no effect on ...

Using sham diplomas and transcripts, buyers could take the national nursing board exam. Those who passed received nursing ...

Among 77,310 adults without diabetes who began taking semaglutide after it was approved for weight loss, 40,262 (52%) were no ...

Consequently, patients were more likely to value PFS due to concerns about maintaining quality of life (32.5%), improving ...